LENZ Therapeutics (LENZ) Retained Earnings: 2022-2023
Historic Retained Earnings for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to -$344.1 million.
- Therapeutics' Retained Earnings fell 58.00% to -$344.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$344.1 million, marking a year-over-year decrease of 58.00%. This contributed to the annual value of -$242.4 million for FY2022, which is N/A change from last year.
- According to the latest figures from Q3 2023, Therapeutics' Retained Earnings is -$344.1 million, which was down 6.97% from -$321.7 million recorded in Q2 2023.
- In the past 5 years, Therapeutics' Retained Earnings registered a high of -$167.2 million during Q1 2022, and its lowest value of -$344.1 million during Q3 2023.
- Its 2-year average for Retained Earnings is -$250.4 million, with a median of -$242.4 million in 2022.
- Data for Therapeutics' Retained Earnings shows a maximum YoY crashed of 66.58% (in 2023) over the last 5 years.
- Therapeutics' Retained Earnings (Quarterly) stood at -$242.4 million in 2022, then crashed by 58.00% to -$344.1 million in 2023.
- Its last three reported values are -$344.1 million in Q3 2023, -$321.7 million for Q2 2023, and -$266.3 million during Q1 2023.